1 Newcomb CD, "Timing of cord blood treatment after experimental stroke determines therapeutic efficacy" 15 : 213-223, 2006
2 Kim EH, "Synthesis of ferrofluid with magnetic nanoparticles by sonochemical method for MRI contrast agent" 289 : 328-330, 2005
3 Lee HS, "Synthesis of MRI contrast agent by coating superparamagnetic iron oxide with chitosan" 41 : 4102-4104, 2005
4 Wang YX, "Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging" 11 : 2319-2331, 2001
5 Stauer BE, "Stem cell therapy in perspective" 107 : 929-934, 2003
6 Deans RJ, "Mesenchymal stem cells: biology and potential clinical uses" 28 : 875-884, 2000
7 Harris LA, "Magnetic nanoparticle dispersions stabilized with triblock copolymers" 15 : 1367-1377, 2003
8 Arbab AS, "Labeling of cells with ferumoxides. Protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoitic or mesenchymal stem cells" 18 : 553-559, 2005
9 Werner N, "Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury" 93 : 17-24, 2003
10 Ittrich H, "In vivo magnetic resonance imaging of iron oxide labeled arterially injected mesenchymal stem cells in kidney of rats with acute ischemic kidney injury: detection and monitoring at 3T" 25 : 1179-1191, 2007
1 Newcomb CD, "Timing of cord blood treatment after experimental stroke determines therapeutic efficacy" 15 : 213-223, 2006
2 Kim EH, "Synthesis of ferrofluid with magnetic nanoparticles by sonochemical method for MRI contrast agent" 289 : 328-330, 2005
3 Lee HS, "Synthesis of MRI contrast agent by coating superparamagnetic iron oxide with chitosan" 41 : 4102-4104, 2005
4 Wang YX, "Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging" 11 : 2319-2331, 2001
5 Stauer BE, "Stem cell therapy in perspective" 107 : 929-934, 2003
6 Deans RJ, "Mesenchymal stem cells: biology and potential clinical uses" 28 : 875-884, 2000
7 Harris LA, "Magnetic nanoparticle dispersions stabilized with triblock copolymers" 15 : 1367-1377, 2003
8 Arbab AS, "Labeling of cells with ferumoxides. Protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoitic or mesenchymal stem cells" 18 : 553-559, 2005
9 Werner N, "Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury" 93 : 17-24, 2003
10 Ittrich H, "In vivo magnetic resonance imaging of iron oxide labeled arterially injected mesenchymal stem cells in kidney of rats with acute ischemic kidney injury: detection and monitoring at 3T" 25 : 1179-1191, 2007
11 Kostura L, "Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis" 17 : 513-517, 2004
12 Arbab AS, "Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI" 104 : 1217-1223, 2004
13 Cheng SL, "Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone" 134 : 277-286, 1994
14 Berry CC, "Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro" 24 : 4551-4557, 2003
15 Bulte JW, "Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides" 104 : 3410-3413, 2004
16 Mackay AM, "Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow" 4 : 415-428, 1998
17 Sinha VR, "Chitosan microspheres as a potential carrier for drugs" 274 : 1-33, 2004
18 Arbab AS, "Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging" 229 : 838-846, 2003
19 Bowen CV, "Application of the static dephasing regime theory to superparamagnetic iron-oxide loaded cells" 48 : 52-61, 2002
20 Taguchi A, "Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model" 114 : 330-338, 2004